IGC Pharma Inc (IGC)
0.3525
+0.02
(+5.76%)
USD |
NYAM |
Nov 21, 16:00
0.3491
0.00 (0.00%)
After-Hours: 07:56
IGC Pharma Debt to Equity Ratio: 0.0183 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.0183 |
| June 30, 2024 | 0.0173 |
| March 31, 2024 | 0.0187 |
| December 31, 2023 | 0.0152 |
| September 30, 2023 | 0.0099 |
| June 30, 2023 | 0.0106 |
| March 31, 2023 | 0.0095 |
| December 31, 2022 | 0.0077 |
| September 30, 2022 | 0.007 |
| June 30, 2022 | 0.0066 |
| March 31, 2022 | 0.006 |
| December 31, 2021 | 0.005 |
| September 30, 2021 | 0.0048 |
| June 30, 2021 | 0.0047 |
| March 31, 2021 | 0.0177 |
| December 31, 2020 | 0.027 |
| September 30, 2020 | 0.0246 |
| June 30, 2020 | 0.0253 |
| March 31, 2020 | 0.0019 |
| December 31, 2019 | 0.0017 |
| September 30, 2019 | 0.0016 |
| June 30, 2019 | 0.0015 |
| March 31, 2019 | 0.0015 |
| December 31, 2018 | 0.0018 |
| September 30, 2018 | 0.1467 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.2674 |
| March 31, 2018 | 0.2761 |
| December 31, 2017 | 0.339 |
| September 30, 2017 | 0.4094 |
| June 30, 2017 | 0.3874 |
| March 31, 2017 | 0.3593 |
| December 31, 2016 | 0.3801 |
| September 30, 2016 | 0.1958 |
| June 30, 2016 | 0.1941 |
| March 31, 2016 | 0.2092 |
| December 31, 2015 | 0.2282 |
| September 30, 2015 | 0.229 |
| June 30, 2015 | 0.2742 |
| March 31, 2015 | 0.2443 |
| December 31, 2014 | 0.2143 |
| September 30, 2014 | 0.2218 |
| June 30, 2014 | 0.1987 |
| March 31, 2014 | 0.1633 |
| December 31, 2013 | 0.153 |
| September 30, 2013 | 0.154 |
| June 30, 2013 | 0.1614 |
| March 31, 2013 | 0.1556 |
| December 31, 2012 | 0.1524 |
| September 30, 2012 | 0.1544 |
| June 30, 2012 | 0.1538 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0017
Minimum
Dec 2019
0.027
Maximum
Dec 2020
0.012
Average
0.0097
Median
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.9382 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Protalix BioTherapeutics Inc | 0.00 |
| Palatin Technologies Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.37M |
| Total Liabilities (Quarterly) | 2.992M |
| Shareholders Equity (Quarterly) | 7.377M |
| Current Ratio | 1.517 |
| Net Debt Paydown Yield | 0.00% |